Literature DB >> 301079

Catabolic rate of alpha1-antitrypsin of Pi type M and Z in man.

C B Laurell, B Nosslin, J O Jeppsson.   

Abstract

1. Human alpha1-antitrypsin was isolated from three Pi M and two Pi Z subjects without alteration of its microheterogeneity. The purified proteins were labelled with either 125I or 131I by a lactoperoxidase method. 2. The disappearance rate of two types of alpha1-antitrypsin were studied after simultaneous injection of labelled M-protein and Z-protein into Pi M subjects. 3. The ratio of extravascular to plasma pools of alpha1-antitrypsin ranged between 1-2 and 1-6 with no difference between M- and Z-protein. The mean fractional catabolic rates of M-protein and Z-protein were respectively 0-26 and 0-40 per day. 4. The difference in catabolic rate of Z- and of M-protein is too small to explain why the alpha1-antitrypsin content of the blood in Pi ZZ subjects is only 15% of that normally found in Pi MM subjects. The low alpha1-antitrypsin in Pi ZZ subjects appears mainly to be due to a low rate of biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301079     DOI: 10.1042/cs0520457

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  9 in total

1.  The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA.

Authors:  D H Perlmutter; R M Kay; F S Cole; T H Rossing; D Van Thiel; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Turnover of autologous alpha 1-antitrypsin in a patient with congenital analbuminemia.

Authors:  K Weigand; E Russi; G von Schulthess; C Bavaud
Journal:  Klin Wochenschr       Date:  1983-06-01

3.  Antigen-antibody crossed electrophoretic studies and quantitative comparisons of serum transferrin types in horses.

Authors:  N Ek
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

4.  Ascitic fluid alpha 1-antitrypsin.

Authors:  F G Villamil; P B Sorroche; H F Aziz; P M Lopez; J M Oyhamburu
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

5.  Design and characterization of an APC-specific serpin for the treatment of hemophilia.

Authors:  Stéphanie G I Polderdijk; Ty E Adams; Lacramioara Ivanciu; Rodney M Camire; Trevor P Baglin; James A Huntington
Journal:  Blood       Date:  2016-10-27       Impact factor: 22.113

6.  Multiple tissues express alpha 1-antitrypsin in transgenic mice and man.

Authors:  J A Carlson; B B Rogers; R N Sifers; H K Hawkins; M J Finegold; S L Woo
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats.

Authors:  Huong L Moldthan; Aaron C Hirko; Jeffrey S Thinschmidt; Maria B Grant; Zhimin Li; Joanna Peris; Yuanqing Lu; Ahmed S Elshikha; Michael A King; Jeffrey A Hughes; Sihong Song
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-02-28       Impact factor: 2.136

8.  Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.

Authors:  Eeva Piitulainen; Elisabeth Bernspång; Sven Björkman; Erik Berntorp
Journal:  Eur J Clin Pharmacol       Date:  2003-05-01       Impact factor: 2.953

9.  Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro.

Authors:  Ruta Aldonyte; Lennart Jansson; Sabina Janciauskiene
Journal:  BMC Cell Biol       Date:  2004-03-29       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.